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Assembly of the herpesvirus tegument is poorly understood but is believed to involve interactions between outer tegument pro-
teins and the cytoplasmic domains of envelope glycoproteins. Here, we present the detailed characterization of a multicompo-
nent glycoprotein-tegument complex found in herpes simplex virus 1 (HSV-1)-infected cells. We demonstrate that the tegument
protein VP22 bridges a complex between glycoprotein E (gE) and glycoprotein M (gM). Glycoprotein I (gI), the known binding
partner of gE, is also recruited into this gE-VP22-gM complex but is not required for its formation. Exclusion of the glycopro-
teins gB and gD and VP22’s major binding partner VP16 demonstrates that recruitment of virion components into this complex
is highly selective. The immediate-early protein ICP0, which requires VP22 for packaging into the virion, is also assembled into
this gE-VP22-gM-gI complex in a VP22-dependent fashion. Although subcomplexes containing VP22 and ICP0 can be formed
when either gE or gM are absent, optimal complex formation requires both glycoproteins. Furthermore, and in line with com-
plex formation, neither of these glycoproteins is individually required for VP22 or ICP0 packaging into the virion, but deletion
of gE and gM greatly reduces assembly of both VP22 and ICP0. Double deletion of gE and gM also results in small plaque size,
reduced virus yield, and defective secondary envelopment, similar to the phenotype previously shown for pseudorabies virus.
Hence, we suggest that optimal gE-VP22-gM-gI-ICP0 complex formation correlates with efficient virus morphogenesis and
spread. These data give novel insights into the poorly understood process of tegument acquisition.
The herpesvirus virion is a complex particle consisting of aDNAgenome-containing capsid surrounded by a compartment
termed the tegument and an outer, host cell-derived lipid enve-
lope that contains virus-encoded glycoproteins (29). The proto-
typic alphaherpesvirus herpes simplex virus 1 (HSV-1) packages
at least 26 tegument proteins and up to 20 envelope proteins (35).
Because of this complexity and previously recognized redundancy
among the structural proteins, the molecular mechanisms in-
volved in the assembly of this virus remain poorly understood. An
attractive andwidely acceptedmodel proposes that viral glycopro-
teins embedded within membranes of the late secretory pathway
recruit components of the outer tegument, through which viral
capsids, surrounded by an inner tegument, bud to produce ma-
ture virions (25, 33). In spite of this favored model, there are few
examples in the literature of well-defined tegument-glycoprotein
interactions shown to be involved in virus assembly. For example,
the major tegument components VP16 and VP22 have been re-
ported to interact with gH and gD, respectively, but the contribu-
tion these interactionsmake to tegument assembly and virusmor-
phogenesis have not yet been proven (5, 17, 20).
The nonessential glycoprotein gE is the only envelope protein
thus far convincingly shown to interact directly with and be re-
quired for the recruitment of individual tegument proteins into
the alphaherpesvirus virion. In HSV-1, gE has recently been
shown to be required for the packaging of the membrane-bound
tegument protein UL11 via an interaction between the cytoplas-
mic tail of gE and the C terminus of UL11, thereby representing
the only published example of a single glycoprotein being required
to package a tegument protein (17, 22). The cytoplasmic tail of gE
has also been shown to interact with the tegument protein VP22, a
protein that is also not essential for virus assembly (11). This was
first demonstrated in pseudorabies virus (PRV), where yeast two-
hybrid assays indicated such an interaction (19). More recently, a
similar interaction has been identified between HSV-1 VP22 and
the cytoplasmic tail of gE of HSV-1 (17, 43, 49). The relationship
between the HSV-1 proteins has been explored in detail and has
been shown using pulldown of VP22 on aGST-gE cytoplasmic tail
fusion protein, relocalization of VP22 to Golgi-localized gE in
cotransfected cells, and coimmunoprecipitations from infected
cells (43, 49). A conserved C-terminal domain of VP22was shown
to coprecipitate gE in infected cells, and importantly, deletion of a
12-residue region in this domain abrogated both interaction with
gE and assembly of VP22 into the virion (21, 43, 49).
Nonetheless, unlike the UL11-gE interaction, a paradox exists
with the gE/VP22 complex in PRV as a virus lacking gE, and its
partner gI in PRV is still able to package full-length VP22 to wild-
type levels (19). In the case of HSV-1, it has been reported that
virus lacking the cytoplasmic tail of gE (22) also packages VP22 to
wild-type levels. Hence, these results suggest an alternative assem-
bly pathway for VP22 that utilizes the same essential C-terminal
region. VP22 is known to interact with a second major tegument
protein, VP16, but this interaction is not required to package
VP22 into the virion (12, 21, 43). A second candidate for an alter-
native packaging route is the cytoplasmic tail of the glycoprotein
gM. Like gE and VP16, HSV-1 gM has been shown to coimmuno-
precipitate with VP22 in infected cells (49). Direct binding studies
between VP22 and gM from PRV and HSV-1 have also indicated
the potential for these two proteins to interact directly, but in
HSV-1 at least this interaction was much less convincing than the
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aforementioned gE-VP22 interaction (49). Furthermore, unlike
the case forHSV-1VP22 and gE, coexpression ofHSV-1VP22 and
gM by cotransfection of expressing plasmids revealed no ability of
gM to relocalize VP22 to the Golgi region, leaving the significance
of the VP22-gM interaction unclear (49). Nonetheless, simultane-
ous deletion of gE, its known binding partner gI, and gM in PRV
was shown to completely abrogate VP22 assembly into the virion
(19). As single deletions of gM in both PRV and HSV-1 have been
shown to be dispensable for VP22 incorporation into the virion
(19, 46), it would seem that it is the combination of the gE/gI and
gM deletions that abolishes VP22 assembly in PRV virions.
Taken together, this combination of data hints at the presence
of an as-yet poorly characterized network of protein-protein in-
teractions involving VP22, which is required for VP22 virion in-
corporation. Furthermore, asVP22 is required for virion assembly
of the immediate-early protein ICP0 (11, 38), it is likely that any
interaction that impinges on the recruitment of VP22 to the virus
particle will indirectly affect ICP0 assembly. In this paper, we
demonstrate that gE forms a specific complex with gM in the
infected cell that is dependent on the presence of VP22. This com-
plex also contains the gE binding partner gI and the VP22 partner
ICP0 but does not recruit gD or gB or the well-characterized
VP22-binding protein VP16. We show that gE, gM, and gI are
individually dispensable for VP22 virion incorporation in HSV-1
but that a virus lacking both gE and gM in combination packages
greatly reduced levels of both VP22 and ICP0. The phenotype of
this double glycoprotein mutant virus—small plaque size, re-
duced virus yield, and defective secondary envelopment as deter-
mined by electron microscopy—suggests that formation of this
multicomponent complex is important for efficient virus produc-
tion. This study represents the first detailed characterization of a
higher-order glycoprotein-tegument complex in infected cells in-
volved in the recruitment of several tegument proteins into the
herpesvirus particle. Our data therefore provide valuable new in-
sights into the molecular mechanisms that underpin the most
widely accepted model for herpesvirus morphogenesis.
MATERIALS AND METHODS
Cells and viruses.Vero cells were cultured inDulbecco’smodified Eagle’s
medium supplemented with 10% newborn calf serum and antibiotics.
HFFF cells were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% fetal bovine serum and antibiotics.
The wild-type HSV-1 strain sc16 and the gE, gEgM, and gI mu-
tants were kindly provided by Helena Browne (2, 4), and the gM virus
was kindly donated by Colin Crump (46) (both from the University of
Cambridge, Cambridge, United Kingdom). Our 22 virus expressing
green fluorescent protein (GFP) in place of VP22 (169v) (11) and our
GFP-22mutant expressingGFP-tagged full-length VP22 (166v) (14) have
been described previously. Our gEbind virus, which expresses GFP-
tagged VP22 with a small lesion within the gE-binding domain of VP22, is
also described elsewhere (49). Viruses expressing GFP tagged to residues
108 to 301, 160 to 301, and 212 to 301 of VP22 and GFP tagged to variants
of VP22 expressing mutated phosphorylation sites have been described
before (21, 45). Extracellular virions were purified on Ficoll gradients
from the infected cell medium of between 3 108 and 1 109 Vero cells,
as described previously (14). Viruses were routinely titrated on Vero cells.
Antibodies. The gD (LP14), VP16 (LP1), gB (R69), and gM (Ab980)
antibodies were kindly provided by Tony Minson and Helena Browne
(University of Cambridge). Antibodies specific for gE (3114), gE in the
context of the gE-gI complex (3063), and gI (3104) were kindly donated
byDavid Johnson (OregonHealth and ScienceUniversity, Portland,OR).
The gE antibody 3114 was used for Western blotting only; for immuno-
precipitations, we used a commercially available gE antibody (ab6510)
(AbCam, Cambridge, United Kingdom). The VP5 (3B6) and ICP0
(11060) antibodies are also commercially available from Virusys (Taney-
town, MD) and Santa Cruz (Santa Cruz, CA), respectively. Our VP22-
specific antibodies AGV600 and AGV031 are described elsewhere (13)
and were used for immunoprecipitations and Western blotting, respec-
tively. Horseradish peroxidase-conjugated secondary antibodies were
purchased from Bio-Rad Laboratories (Hercules, CA). For gM and VP22
Western blots of immunoprecipitation samples, the TrueBlot horseradish
peroxidase-conjugated rabbit secondary antibody (eBioscience, San Di-
ego, CA), which does not recognize denatured immunoglobulin, was
used.
SDS-PAGE and Western blotting. Protein samples were analyzed on
10% polyacrylamide gels and subjected to electrophoresis in Tris-glycine
buffer. All samples were boiled for 3 min prior to electrophoresis except
for those used for gM blots, which were heated to 42°C for 20 min. Gels
were then either stained inCoomassie blue or transferred to nitrocellulose
membrane for Western blot analysis using antibodies as indicated. West-
ern blots were developed using SuperSignal West Pico chemiluminescent
substrate (Thermo Fisher Scientific).
Immunoprecipitation assay. Vero cells grown in 6-cm dishes were
infected with the relevant viruses at a multiplicity of 1. After 24 h, the cells
were washed twice with phosphate-buffered saline (PBS), solubilized in 1
ml radioimmunoprecipitation assay (RIPA) buffer (50mMTris [pH 7.5],
150 mM NaCl, 0.1% SDS, 1% Na deoxycholate, 1% NP-40, protease in-
hibitors) and incubated on ice for 20min. The cells were then centrifuged
at 12 K for 30 min at 4°C, and the supernatant was collected. The super-
natant was precleared with protein A Sepharose beads at a sample-bead
ratio of 10:1 for 1 h at 4°C with rotation. The precleared lysate was then
incubated with antibody at a sample-antibody ratio of 100:1 (monoclo-
nal) or 40:1 (polyclonal) at 4°C for 3 h with rotation. Protein A Sepharose
beads were added at a sample-bead ratio of 10:1 and incubated for 1 h at
4°C with rotation, and the resulting protein A-antibody complexes were
washed three times in a buffer consisting of 50mMTris-HCl (pH7.5), 150
mM NaCl, and 1% (vol/vol) NP-40. The immunoprecipitated proteins
were then analyzed by SDS-PAGE followed by Western blotting.
Expression and purification of GST-tagged proteins. Plasmid ex-
pressing GST fused to the C-terminal 126 residues of glycoprotein M was
kindly provided by Colin Crump (University of Cambridge). GST-gM
and GST alone were expressed in Escherichia coli strain BL21 by inducing
a 250-ml culture with 1 mM IPTG (isopropyl--D-thiogalactopyrano-
side) followed by a further 3-h incubation. The cells were then pelleted,
resuspended in 10 ml PBS containing protease inhibitors and 1 mg/ml
lysozyme, and left on ice for 30 min. Following sonication, Triton X-100
was added to 1%, and the extracts were incubated for a further 30 min of
rotating at 4°C and centrifuged at 4 K for 30 min at 4°C. The soluble
supernatant was added to 200 l of a 50:50 suspension of glutathione
Sepharose beads and rotated for 1 h at 4°C, and the unbound protein was
washed off the beads by 3 washes with PBS.
Pulldown of infected cell extracts on GST-tagged proteins.Vero cells
in 6-cm dishes were infected with the relevant viruses, and 16 h later cells
were washed with PBS and harvested in 1ml lysis buffer (50mMTris [pH
7.5], 200 mM NaCl, 2 mM MgCl, 1% NP-40, and protease inhibitors).
The samples were left on ice for 20min and centrifuged at 12 K for 30min
at 4°C. A total of 400 l of supernatant was mixed with the relevant GST
fusion protein already bound to glutathione Sepharose beads. Following 2
to 3 h of rotating at 4°C, the beads were washed 3 times with lysis buffer,
and samples of each were analyzed by SDS-PAGE and Western blotting.
Transmission electron microscopy. Cells for electron microscopy
(EM) were fixed in 0.5% glutaraldehyde in 200 mM sodium cacodylate
buffer for 30 min, washed in buffer, and secondarily fixed in reduced 1%
osmium tetroxide and 1.5% potassium ferricyanide for 60 min. The sam-
ples were washed in distilled water and stained overnight at 4°C in 0.5%
magnesium uranyl acetate, washed in distilled water, and dehydrated in
graded ethanol. The samples were then embedded flat in the dish in Epon
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resin. Resin-filled stubs were placed on embedded cell monolayers and
polymerized. Ultrathin sections (typically 50 to 70 nm) were cut parallel
to the dish and examined in an FEI Tecnai electron microscope with
charge-coupled-device (CCD) camera image acquisition.
RESULTS
Characterization of HSV-1 lacking gE and/or gM. The starting
point for this work was our existing data that both gE and gM
coimmunoprecipitate with VP22 in infected cell lysates (49). Such
a result could indicate either two different VP22-glycoprotein
complexes or a single complex comprising all three proteins. To
further examine the relationship between VP22, gE, and gM, we
made use of viruses lacking expression of gE (gE), gM (gM), or
both gE and gM (gEgM) based on the wild-type (WT) strain
sc16, kindly provided by Helena Browne and Colin Crump (Uni-
versity of Cambridge). In PRV, it has been shown that simultane-
ous deletion of gE, gI, and gM results in a 1,000-fold drop in virus
production (3) but in HSV-1 double deletion of gE and gM has
been characterized as having limited but variable effects on virus
replication depending on cell type (4). Before using the HSV-1
mutants in our studies for protein-protein interactions, we first
characterized their growth in Vero cells. Plaque analysis indicated
that, as expected from previous studies (4), all three mutant vi-
ruses formed plaques on Vero cells, but they exhibited reduced
plaque size compared to that of the WT, with the plaques size of
the double-deletion mutant being over 5-fold less than that of the
WT (Fig. 1A). In the case of the gM mutant, its plaque size was
similar to that published before (46). Furthermore, one-step
growth curves showed that the relative plaque size of the virus
mutants correlated with their ability to replicate in a single cycle,
with the single mutants producing and releasing around 8-fold
less virus while the double mutant produced up to 50-fold less
virus than the WT virus (Fig. 1B). Although the defects in virus
replication that we observed were not as extensive as those ob-
served in the PRV study, it should be noted firstly that, in the PRV
study, gI had also been deleted and secondly that the differences
we observed in the replication of thegEgMdouble-deletionmu-
tant in HSV was more substantial than described previously (4).
Coimmunoprecipitation of gM and gE with VP22. The re-
quirement for gE and gM in each other’s interaction with VP22
was examined by immunoprecipitating VP22 from Vero cells in-
fected with each of the above-described viruses, with our previ-
ously described VP22-null (22) virus acting as a negative control
(11).Western blotting of the input extracts indicated that the pro-
teins being examined were expressed to similar levels in all infec-
tions with the exception of the 22 infection (Fig. 2A, input),
which we have shown previously to express reduced levels of virus
proteins (11). Coimmunoprecipitation of gE with VP22 was
clearly detected in cells infected withWT virus andwas unaffected
by the absence of gM, indicating that gM is not required to form
the gE-VP22 complex in infected cells (Fig. 2A, VP22 IP). Impor-
FIG 1 Growth characteristics ofHSV-1 lacking gE and/or gM. (A)Vero cells in 6-well plates were infectedwith approximately 100 PFUofWT (sc16),gE,gM,
or gEgM viruses and fixed and stained 4 days later. The area of 20 representative plaques for each virus was measured using ImageJ software, and the average
relative size was calculated as a percentage ofWT plaques. (B) Single-step growth curves ofWT,gE,gM, orgEgM viruses were carried out by infecting Vero
cells at a multiplicity of 5 and harvested at the indicated times for cell-associated or released virus. All growth curves were carried out in triplicate.
HSV-1 Glycoprotein-Tegument Network
December 2012 Volume 86 Number 23 jvi.asm.org 12973
 o
n
 February 22, 2017 by UNIVERSITY O
F SURREY
http://jvi.asm.org/
D
ow
nloaded from
 
tantly, neither gD nor gB precipitated with VP22 in WT-infected
cells, confirming that VP22 does not indiscriminately bind all gly-
coproteins (Fig. 2A). In contrast, although gM coimmunoprecipi-
tated with VP22 fromWT-infected cells, only trace amounts pre-
cipitated with VP22 in the absence of gE (Fig. 2B). Interestingly,
VP22 expressed in the absence of gE migrated more slowly on the
gel compared to VP22 expressed in the presence of gE, suggesting
that gE is in some way required for the appropriate modification
of VP22 during infection (Fig. 2A). As this slow-migrating form
has previously been shown to represent phosphorylated VP22,
with the faster-migrating form representing nonphosphorylated
VP22 (15, 16), it seems plausible that gE is somehow required for
the expression of VP22 lacking phosphorylation.
To determine if the interaction of VP22 with its other known
tegument binding partners was affected by the absence of gE
and/or gM, VP22 coimmunoprecipitations were also tested for
the presence of VP16 or ICP0 (Fig. 2C). Interestingly, VP16 coim-
munoprecipitated efficiently with VP22 in all infected cell lysates
(Fig. 2C, VP16), indicating that neither gE nor gM is required in
the formation of the VP22-VP16 complex. However, the presence
of ICP0 in the VP22-specific complex was greatly reduced when
either of the glycoproteins was absent (Fig. 2C, ICP0), suggesting
that the interaction of ICP0 with VP22 may be facilitated by both
glycoproteins.
gE forms a VP22-dependent complex with gM. To further
examine the nature of these complexes, we next immunoprecipi-
tated gE from infected cells. Here, the gE mutant served as a
negative control. As expected from the reciprocal VP22 immuno-
precipitations, VP22 bound to gE fromWT-infected cells (Fig. 3A,
wt). Furthermore, VP22 interacted with gE in the absence of gM
(Fig. 3A, gM). Interestingly, we were also able to routinely co-
precipitate gMwith gE fromWT-infected cells (Fig. 3A andB,wt),
demonstrating that gE and gM exist in a complex in the infected
cell. Importantly, the lack of gD pulldown in the gE immunopre-
cipitation shows that gE does not indiscriminately bind all viral
glycoproteins (Fig. 3B). In addition, VP16 did not precipitate with
gE, confirming that the VP22-VP16 complex is distinct from the
gE-VP22 complex (Fig. 3C).
We next repeated these gE immunoprecipitations with the22
virus and our previously described HSV-1 mutants expressing
GFP-tagged full-length VP22 (GFP-22) (14) or GFP-tagged VP22
with a small lesion within the conserved gE-binding domain of
VP22 (49) (Fig. 3D, gEbind). Similarly to WT HSV-1, gE coim-
munoprecipitated VP22 and gM from cells infected with the
GFP-22 virus (Fig. 3E). As shown previously by VP22 immuno-
precipitation (49), VP22 did not interact with gE in cells infected
with the gEbind mutant. Interestingly, gM did not bind gE in
cells infected with thegEbind or VP22-null viruses, demonstrat-
ing that an interaction between gE and VP22 is required for for-
mation of the gE-gMcomplex.Moreover, ICP0was also present in
the gE-specific complex inWT-infected cells but was absent from
gE-specific complexes lacking VP22 (Fig. 3E, ICP0), confirming
that ICP0 is recruited into the gE-VP22-gM complex in a VP22-
dependent fashion. As our previous studies had shown that the
C-terminal half of VP22 (160 to 301 in Fig. 3D) was sufficient for
assembly of VP22 into the virion (21), we next tested the ability of
this region of VP22 to interact with gE and/or gM during infec-
tion. Coimmunoprecipitation of VP22 from cells infected with
HSV-1 expressing GFP 160 to 301 revealed that both gE and gM
were able to complex with the C-terminal half of VP22 (Fig. 3F).
In contrast, ICP0 was not present in this multicomponent com-
plex, indicating that the N-terminal half of VP22 is likely to be
involved in bringing ICP0 into this complex (Fig. 3F, ICP0). This
confirms our previous data showing a requirement for the N ter-
minus of VP22 in the assembly of ICP0 into the virion (38). Col-
lectively, our data show that VP22, ICP0, gE, and gM are present
within the same complex in infected cells and that, although VP22
is not essential for virus assembly, it is fundamental to the forma-
tion of this multicomponent complex.
VP22 expressed in the absence of gE can bind to the cytoplas-
mic domain of gM. The above-described data demonstrate that
gM requires VP22 to form a complex with gE. As it was difficult to
detect a complex between gM and VP22 in the absence of gE (Fig.
2B), it is possible that gE is somehow required for formation of a
VP22-gM complex. We were unable to investigate complex for-
mation by immunoprecipitation of gM because the antibody
FIG 2 Immunoprecipitation of VP22-specific complexes from cells infected
with viruses lacking gE and/or gM. (A to C) Whole-cell lysates harvested 24 h
after infection from Vero cells infected with 22, sc16 (wt), gE, gM, or
gEgM viruses were subjected to immunoprecipitation with an anti-VP22
antibody and analyzed by Western blotting for the presence of gE, gD, or gB
(A), gM (B), and VP16 or ICP0 (C). *, immunoglobulin heavy chain; note that
the immunoglobulin heavy chain is visible in this gM blot, and no others,
because the ordinary rabbit secondary antibody, rather than the TrueBlot sec-
ondary antibody, was used here.
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available to us is a rabbit polyclonal antibody that in our hands
routinely nonspecifically coprecipitated the gE-gI Fc receptor
complex (data not shown).Hence, to determine if VP22 expressed
in gE-infected cells was capable of binding gM, we carried out
pulldown assays of infected cell extracts using a GST-gM (cy-
toplasmic tail) fusion protein bound to glutathione Sepharose
beads, as described previously (49). The resulting complexes
bound to gMwere then analyzed byWestern blotting for the pres-
ence of VP22.We first confirmed that the pulldown from infected
cells reproduced our results fromVP22 coimmunoprecipitations,
by carrying out pulldowns with extracts from cells infected with
viruses expressing truncated versions of VP22 (Fig. 4A). These
confirmed that region 160 to 301 of VP22, the region that coim-
munoprecipitates gE and gM and is packaged into virions (21),
was able to bind to the cytoplasmic tail of gM in vitro (Fig. 4B).We
next tested the pulldown of VP22 expressed in cells infected with
the gE and gM deletion mutants. Interestingly, these showed that,
in spite of not efficiently coimmunoprecipitating gM, the VP22
population present ingE-infected cells had the ability to interact
with GST-gM in the absence of gE (Fig. 4C).
Data presented in Fig. 1B suggest that there may a correlation
between posttranslational modification of VP22 and its ability to
FIG 3 VP22 bridges gE and gM to formamulticomponent complex in infected cells. (A toC)Vero cells were infectedwithWTHSV-1 or thegE orgMviruses,
and gEwas immunoprecipitated fromwhole-cell lysates harvested 24 h using antibody ab6510. Samples were subjected toWestern blot analysis using antibodies
specific for gE, gM, VP22, gD, or VP16. *, immunoglobulin heavy chain. (D) Schematic illustrating our previously described VP22 mutant viruses expressing
GFP-tagged full-length VP22 (GFP-22), GFP in place of VP22 (22), GFP-tagged VP22 with a deletion between residues 213 to 226 (gEbind), or GFP tagged
to the C-terminal half of VP22 (160 to 301). (E and F) As for panel A, except Vero cells were infected with the viruses described in panel D or thegEmutant and
samples analyzed by Western blotting using antibodies specific for gE, gM, VP22, GFP, or ICP0. Molecular weight marker sizes (kDa) are shown on the left.
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bind gM.We therefore tested binding of gM to two other variants
of VP22 in which the previously identified phosphorylated resi-
dues had been mutated to alanines to mimic nonphosphorylated
VP22 (P) or to glutamic acids to mimic the phosphorylated
form of VP22 (P) (45). Using cell extracts from infections with
HSV-1 expressing either of these two variants, we found that VP22
with a constitutively high negative charge at its phosphorylation
sites (P) consistently bound to gM with less efficiency than the
noncharged version (Fig. 4D). Taken together, these results sug-
gest that VP22 from infected cells has the ability to bind to gM in
the absence of gE but that the prevalence of modified/negatively
charged VP22 may limit the efficiency or stability of this interac-
tion as detected by coimmunoprecipitations.
The gE-VP22-gM complex also incorporates gI. In infected
cells, gE interacts with gI to form the HSV-1 Fc receptor (26). We
therefore sought to determine whether gI is also recruited into the
gE-VP22-gM complex or whether a separate gE-gI complex exists.
Initial attempts to determine if gI coprecipitated with VP22 were
hampered by our inability to detect gI in infected cell lysates with
the monoclonal antibody available to us (data not shown). To
overcome this issue, we made use of an alternative monoclonal
antibody (3063) that reportedly recognizes gE only in the context
FIG 4 VP22 interaction with the cytoplasmic tail of gM. (A) Schematic of VP22 variants expressed by recombinant viruses used in panels B and D. (B to D)
GST-gM (gM) orGST alone (G) bound to glutathione Sepharose beads was incubatedwith lysates fromVero cells infectedwith viruses as indicated and analyzed
by SDS-PAGE followed by Western blotting for GFP (B and D) or VP22 (C). Molecular weight marker sizes (kDa) are shown on the left.
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of gI (6).We validated the specificity of this antibody by using it to
immunoprecipitate the gE-gI complex from cells infected with
WTHSV-1, thegEmutant, or thegImutant. Once again, no gI
was observed in the input cell lysate or following gE-gI immuno-
precipitation (Fig. 5A). However, the fact that this antibody im-
munoprecipitated gE from cells infected with the WT virus but
not thegI virus, despite equivalent levels of gE expression in both
viruses (Fig. 5A, input), confirms that this antibody recognizes gE
only when incorporated into the gE-gI complex. When we re-
peated this experiment, we found that gM consistently coimmu-
noprecipitated with gE using this antibody (Fig. 5B). In addition,
VP22 precipitation with gE was also observed with this antibody
(Fig. 5C). These data demonstrate that at least a proportion of the
gE recruited into the VP22 packaging complex is also bound to gI.
The fact that gB was not coimmunoprecipitated with the gE-gI
complex (Fig. 5C) reconfirms that the VP22 packaging complex
does not indiscriminately incorporate all viral glycoproteins.
We next evaluated the impact gI deletion has on the formation
of the VP22 complex itself. Glycoprotein E was immunoprecipi-
tated from Vero cells infected with the WT and gI viruses; the
gE mutant served as a negative control. Note that the gE anti-
body (ab6510) used here and in experiments depicted in Fig. 2
recognizes free gE as well as gE in the context of gI. As before, both
gM and VP22 coimmunoprecipitated with gE from cells infected
with WT virus (Fig. 5D, Wt). Furthermore, comparable levels of
gM and VP22 also coprecipitated with gE in the absence of gI
(Fig. 5D,gI). Hence, although gI is recruited into thismulticom-
ponent packaging complex, we find no evidence to suggest that gI
contributes to its formation.
VP22 fails to package into virions lacking both gE and gM.
The above-described results suggest that although optimal com-
plex formation requires both gE and gM, infected cell VP22 can
interact with the cytoplasmic tail of both glycoproteins in the ab-
sence of each other. To evaluate the roles of gE and gM in VP22
assembly into HSV-1 virions, extracellular particles were gradient
purified from Vero cells infected with WT, gE, gM, or gEgM
viruses and analyzed by SDS-PAGE followed by staining with
Coomassie blue or Western blotting. In several purifications, the
gM and gEgM viruses both proved difficult to purify in large
amounts; however, small but discrete bands were formed during
gradient purification. Coomassie staining of the particles revealed
that although the glycoprotein mutant virions contained a higher
background of overall protein content than the WT virions, the
major components appeared similar, with the exception of the
actin band at 43 kDa, which was greatly enriched in all mutant
virions (Fig. 6A). Western blotting for various components indi-
cated that assembly of gE into the virion is independent of gM, and
vice versa (Fig. 6B), as has been shown previously for PRV (19).
However, although VP22 was packaged into gE and gM
virions to the level of the WT virus, its assembly was greatly re-
duced in gEgM virions (Fig. 6B, VP22). Blotting for another
tegument protein, VP16, showed that this proteinwas packaged at
FIG 5 The gE-VP22-gM complex incorporates gI. (A to C) Vero cells infected withWTHSV-1, thegE virus, or thegI virus (panel A only) were harvested 24
h after infection and the gE-gI complex was immunoprecipitated using antibody 3063, specific for gE in the context of the gE-gI complex. Samples were analyzed
by Western blotting using antibodies as indicated. (D) Vero cells infected with WT HSV-1 or the gE or gI viruses were harvested for 24 h, and gE was
immunoprecipitated using antibody 6510, specific for free and gI-complexed gE. Samples were analyzed byWestern blotting using antibodies specific for gE, gM,
or VP22.
HSV-1 Glycoprotein-Tegument Network
December 2012 Volume 86 Number 23 jvi.asm.org 12977
 o
n
 February 22, 2017 by UNIVERSITY O
F SURREY
http://jvi.asm.org/
D
ow
nloaded from
 
equivalent levels in all viruses, and hence the reduction of VP22 in
the absence of both gE and gM was specific (Fig. 6B, VP16). In
contrast, ICP0 packaging directly correlated with the levels of its
binding partner VP22 and as such was diminished only in the
gEgM virions (Fig. 6D, ICP0). We therefore conclude that, as
previously published (38), VP22 is themajor viral determinant for
ICP0 virion incorporation and that the requirement for gE and
gM does not extend beyond their role in facilitating VP22 pack-
aging.
To confirm that gI is not required forVP22 assembly inHSV-1,
extracellular particles from Vero cells infected with WT or gI
viruses were gradient purified and analyzed by SDS-PAGE fol-
lowed by staining with Coomassie blue or Western blotting. Viri-
ons were equalized according to the major capsid protein VP5
(Fig. 6C), and subsequent blotting showed that both VP22 and
ICP0 were efficiently packaged to WT levels in the absence of gI
(Fig. 6D). Interestingly, the gI virions appeared to assemble less
gE but more gM thanWT virions, indicating that the assembly of
these glycoproteins may be linked to gI (Fig. 6D).
Finally, to determine if VP22 is involved in packaging either gE
or gM into the virion, we purified virions from our 22 virus and
its parent s17 and analyzed equivalent amounts as judged by VP5
loading (Fig. 6E). Blotting for VP22 showed that as expected,
VP22 was absent from the 22 virions (Fig. 6F). However, the
levels of gE and gMwere similar in both sets of virions, confirming
that the absence of the tegument protein VP22 has no effect on the
recruitment of these glycoproteins to the virus, as is the case in
PRV (19).
Defective secondary envelopment by HSV-1 in the absence of
both gE and gM. A PRV mutant lacking gE, gI, and gM has been
shown to exhibit a profound defect in envelopment, resulting in
the accumulation of capsids within the cytoplasm (3). Although
the HSV-1 gEgM virus has a less severe phenotype than the
aforementioned PRV mutant when measured by single-step
FIG 6 Relative assembly of VP22 intoHSV-1 virions isolated fromVero cells infectedwith glycoproteinmutant viruses. (A andB)Gradient purified extracellular
sc16 (WT), gE, gM, or gEgM virions were analyzed by Coomassie blue staining (A) or by Western blotting using antibodies as indicated (B). Molecular
weight marker sizes (kDa) are shown on the left. (C and D) Gradient-purified extracellular sc16 (WT) or gI virions were analyzed by SDS-PAGE followed by
Coomassie blue staining (C) or Western blotting with antibodies as indicated (D). Molecular weight marker sizes (kDa) are shown on the left. (E and F)
Extracellular WT (s17) or 22 virions purified from BHK cells were analyzed by Coomassie blue staining (E) or Western blotting using antibodies as indicated
(F). Molecular weight marker sizes (kDa) are shown on the left.
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growth curve, virus yield and plaque size were nonetheless signif-
icantly affected by the absence of these glycoproteins. To compare
the phenotype of theHSV-1mutant to that of PRV, we carried out
ultrastructural studies in HFFF cells, a primary human fibroblast
cell line that we have recently shown to be a good system for such
studies of HSV-1 (24). Plaque assays on HFFF cells indicated that,
as in Vero cells, the gEgM mutant of HSV-1 produced small
plaques compared to those of the WT virus (data not shown).
HFFF cells were infectedwithWTorgEgMvirus at amultiplicity
of 2, fixed, and processed for transmission electronmicroscopy 12
h later. Imaging of the plasma membrane revealed that at this
time, large numbers of virions had been released from WT-in-
fected cells (Fig. 7A). In contrast, few released virions were detect-
able outsidegEgM-infected cells (Fig. 7B).Within the cytoplasm
of WT-infected cells, areas of active virus wrapping were readily
detected both toward the main body of the cell (Fig. 7C) and
toward the periphery (Fig. 7D). IngEgM-infected cells, however,
while a very few wrapped or wrapping capsids were found (Fig.
7F) and normal numbers of capsids were detected in the nucleus
(Fig. 7E and E1), the vast majority of capsids were found as free,
unwrapped capsids throughout the cytoplasm (Fig. 7E, E2, G, and
H). This indicates that reduced virus yield ingEgM-infected cells
FIG 7 HSV-1 lacking glycoproteins E andM is defective in secondary envelopment. HFFF cells infected with theWT or gEgM virus at a multiplicity of 2 were
fixed 12 h later and processed for EM. PM, plasmamembrane; Ca, capsid; GA,Golgi apparatus; NM, nuclearmembrane;WV,wrapped orwrapping virions. Scale
bar 500 nm.
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can be explained by a drop in secondary envelopment levels and
that as previously shown for PRV (3), gE and gMcontribute to this
fundamental process of HSV-1 morphogenesis. In short, the re-
duction in VP22 assembly, poor virus yield, and defective second-
ary envelopment described for PRV lacking gE and gM (3, 19) has
now been verified inHSV-1. Hence, although none of the individ-
ual components of the multicomponent complex identified here
are essential for HSV-1 or PRV, we would suggest that the absence
of this complex from infected cells has a deleterious effect on virus
maturation.
DISCUSSION
The currentmodel for alphaherpesvirusmorphogenesis, based on
many studies of PRV andHSV-1 in particular, involves assembled
capsids translocating from the nucleus to the cytoplasm, where
they acquire inner tegument proteins such as UL36 and UL37. At
the same time, outer tegument proteins are proposed to assemble
onto the cytoplasmic tails of virus glycoproteins embedded in
membranes of the exocytic or endocytic pathways. The capsid/
inner tegument then buds into these outer tegument-coated
membranes to form the mature particle (25, 40). Such a model
would be simple to test if in the assembly process a single glyco-
protein recruited a single tegument protein to the virion. How-
ever, it is clear from studies on both HSV-1 and PRV that the
protein-protein interactions involved in virus assembly present a
muchmore complex scenario, as none of the previously described
interactions, with the exception of gE-UL11, are requisite for as-
sembly of individual tegument proteins, and there is obvious re-
dundancy among these interactions (39).
The networks of protein interactions contributing to virus as-
sembly have been largely extrapolated from in vitro studies fo-
cused primarily on one or two binding partners, and although
large-scale studies have been carried out using yeast two-hybrid
analysis of herpesvirus protein interactions, few of the identified
networks have been validated in infected cells (18, 52). Here, we
have identified a multicomponent glycoprotein-tegument com-
plex present in HSV-1-infected cells that shows individual com-
ponents of the virus involved in a complicated network of inter-
actions. The complex comprises the glycoproteins gE, gM, and gI
and the tegument proteins VP22 and ICP0, and although single
interactions between components of this complex have been iden-
tified before (gE-gI, VP22-gE, VP22-gM, and VP22-ICP0), such a
large multicomponent complex (summarized in Fig. 8) has not
been described before. The intricate nature of the interactions
identified places VP22 at the center of the complex, with its C
terminus binding to the cytoplasmic tails of gE and gM and form-
ing a bridge between them and the N terminus of VP22 recruiting
ICP0 into the complex. Our immunoprecipitations indicate that
VP22-ICP0 complexes can exist in isolation, as demonstrated re-
cently by yeast two-hybrid studies (18, 54), but it is only when
both glycoproteins are present that the complex is efficiently
formed and/or stabilized within the cell, suggesting that gE and
gM may function to stabilize binding of ICP0 by VP22.
Theglycoprotein-bindingdomainofVP22 is conservedamongall
VP22 homologues (41), suggesting that the gE-VP22-gM complex
may be important for alphaherpesvirus replication. Nonetheless,
VP22 is not required for replication of all alphaherpesviruses, be-
ing dispensable for HSV-1 and PRV but essential for VZV and
MDV (9–11, 19, 51). This variable requirement for VP22 may
reflect a differential role in assembly of other virus proteins. As
illustrated in Fig. 8, there is scope for other proteins to be compo-
nents of this large complex. Others have shown that UL11, UL16,
and UL13 all bind to gE, and hence any of these other tegument
proteins may also be incorporated (22, 42, 53). The tegument
complex of UL11, UL16, and UL21 is also shown in Fig. 8, as this
entire trimeric complex also has the potential to be part of the
VP22-gE multicomponent complex (23). Furthermore, in several
herpesviruses, gM is known to bind the UL49.5 gene product gN,
which in HSV-1 is called UL49A because it is not glycosylated (27,
FIG 8 Network of protein-protein interactions around the HSV-1 tegument protein VP22. Solid lines indicate interactions reported in HSV-1 (5, 8, 12, 20, 22,
23, 26, 34, 38, 42, 48–50, 52, 53). Broken lines indicate interactions shown in PRV (19, 27, 28, 55). The glycoprotein-tegument complex characterized here
(complex 1), which is required for VP22 and ICP0 assembly into the virion, is shown in the context of previously reported relevant interactions (19, 38, 49).
Whether UL11, UL16, or UL13 are incorporated into the VP22-gE-gM-gI-ICP0 complex via their known interactions with gE remains to be determined (22, 42,
53). Others have observed VP22-gD binding in infected cells (5, 17); however, this interaction was not reproducible in our own hands (49), and gD was not
detectable in the VP22-gE-gM-gI-ICP0 complex. The previously characterized VP22-VP16 complex, which also incorporates vhs (12, 48, 50) and which was
shownhere to be separate from theVP22 assembly complex, is also illustrated (complex 2). For completion, the tegument proteinVP13/14 has also been included
in the figure. VP13/14 has been shown to interact with the cytoplasmic tail of gM (49) and VP16 (8, 52); however, it is not known which if either of these
interactions is involved in VP13/14 assembly.
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31, 32, 37). Given that the gE glycoprotein binding partner gI is
incorporated into our complex, it is possible that UL49A would
also be present by virtue of its binding to gM. However, it is note-
worthy that the gM-UL49A interaction has not been confirmed in
HSV-1 and that assembly of UL49A itself into the HSV-1 virion
remains contentious (1, 35). Importantly, exclusion of gD and
VP16 from this glycoprotein-tegument assembly demonstrates
that recruitment of virion components into this complex is selec-
tive. Although gD has been described as a binding partner for
VP22 (5, 17), we have been consistently unable to demonstrate
this interaction in our own studies (reference 49 and this study).
Hence, any gD-VP22 interaction that occurs during infection
would appear to play a limited role. Likewise, VP16 has been
shown to interact with VP22 in a well-characterized complex that
can be demonstrated in vitro and in infected cells and may also
include the host shutoff protein vhs (12, 21, 44, 48, 50). Nonethe-
less, this complex is not involved in assembly of either VP22 or
VP16 into the virion (11, 44) and as such is not recruited into the
complex identified here, suggesting that VP16 is recruited to the
virion via an additional route. Interestingly, it has been proposed
that VP16 is packaged either in the outer tegument by gH (as
shown in Fig. 8) or in the inner tegument by VP1/2 (20, 30). The
existence of a VP22-VP16 complex that is not involved in assem-
bly of either component also suggests that this complex plays an
alternative role in infection, which, as indicated in Fig. 8, could be
the regulation of the host shutoff protein vhs activity during in-
fection, as shown by others (47, 50). The tegument protein
VP13/14 has also been included in Fig. 8, as it has been shown to
interact with both gM and VP16 (8, 49, 52). However, the rela-
tionship between VP13/14 and the two complexes shown here
remains to be determined.
It is noteworthy that the absence of gE, but not gI or gM, con-
sistently induced a mobility shift in VP22. Others also observed
this shift during infection withHSV-1 and PRVwithmutations in
gE (22, 36). As nonphosphorylated VP22 is preferentially re-
cruited into WT HSV-1 particles (16), it is tempting to speculate
that gE might help establish or maintain a nonphosphorylated
VP22 subpopulation for assembly into virions. Potential mecha-
nisms for this include gE altering the localization of VP22 so it
would no longer be accessible to casein kinase II or UL13, both of
which are involved in VP22 phosphorylation (7, 16). Alterna-
tively, UL13 could be sequestered by its known binding to gE (42).
Given that VP22-gM binding is also reduced in the absence of gE,
the VP22-gM interaction might also be regulated by VP22 phos-
phorylation. Nonetheless, pulldown of VP22 expressed in the ab-
sence of gE on GST-gM indicated that this population of protein
was capable of binding to gM in vitro, a result which may indicate
that VP22 and/or gM may not localize correctly in the absence of
gE to interact efficiently. We previously reported that gE, but not
gM, was able to recruit VP22 to secretory pathway membranes in
transfected cells, and hence gE may be required for the efficient
compartmentalization of VP22 prior to it interacting with gM
(49).
Relating complex formation to assembly into the virion is not
straightforward. As is the case in PRV (19), the double gE/gM
deletion mutant doesn’t package VP22 but both single mutants
package it to WT levels, suggesting there is redundancy in these
glycoproteins andVP22 can bind to the cytoplasmic tails of gE and
gM. However, as discussed above, VP22 coprecipitates gM poorly
in the absence of gE. VP22-gM association may be dynamic, per-
haps becoming stable only in the presence of gE (see above).
Moreover, ICP0 is also poorly recruited into the VP22-glycopro-
tein complex in the absence of either glycoprotein but is assem-
bled toWT levels in the singlemutant viruses. It is only when both
glycoproteins are absent thatVP22 andhence ICP0 fail to package.
Since the proportion of expressed VP22 recruited into virus par-
ticles remains unknown, an excess of VP22-glycoprotein com-
plexes might form in WT-infected cells compared with the
amount incorporated into virions.
Interestingly, although the virions from the glycoprotein mu-
tants appear to package WT levels of most proteins, the gM and
gEgM virions were noticeably difficult to isolate. In HSV-1, gM
was recently shown to be required for optimal recruitment of the
gH-gL glycoprotein complex into the virus particle, a factor which
may contribute to the phenotype of these viruses (46). Addition-
ally, PRV lacking gE, gI, and gM has been shown to be severely
impaired in the final stages of virion maturation (3, 19). Likewise,
we have shown here that HSV-1 lacking gE and gM is also defec-
tive in secondary envelopment with unwrapped capsids accumu-
lating in the cytoplasm. Although this phenotype may simply re-
flect the lack of gE and gM in this virus, it must be considered that
it could be explained by a combination of the direct absence of gE
and gM and the indirect absence from the virus particle of VP22,
ICP0, and any other as-yet-unidentified components of this com-
plex.
It is often proposed that the nature of protein interactions
within the tegument confers a degree of order upon this virion
compartment, which was previously described as amorphous. To
our knowledge, this paper presents the first detailed description of
a herpesvirus assembly complex in infected cells that incorporates
multiple components. Our data therefore represent an important
step toward understanding how higher-order glycoprotein-tegu-
ment assemblies form during herpesvirus maturation. In the fu-
ture, it will be important to expand these studies to gain a better
understanding of the wider protein interaction networks leading
to assembly of the herpesvirus tegument.
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